Q3 2021 Holdings
Filed 2021-11-15 | 60 holdings | $92.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $19.1M | 120,000 | 20.7% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $13.8M | 255,000 | 14.9% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $12.6M | 1,500,000 | 13.7% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $12.3M | 150,000 | 13.4% |
| Aldeyra Therapeutics Inc(ALDX) | COM | 01438T106 | $6.1M | 700,000 | 6.7% |
| Atea Pharmaceuticals Inc(AVIR) | COM | 04683R106 | $5.3M | 150,000 | 5.7% |
| Aclaris Therapeutics Inc(ACRS) | COM | 00461U105 | $5.0M | 275,000 | 5.4% |
| Bicycle Therapeutics PLC(BCYC) | SPONSORED ADS | 088786108 | $4.2M | 100,000 | 4.5% |
| Allogene Therapeutics Inc(ALLO) | COM | 019770106 | $3.9M | 150,000 | 4.2% |
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $3.2M | 150,000 | 3.4% |
| Compass Pathways PLC(CMPS) | SPONSORED ADS | 20451W101 | $3.0M | 100,000 | 3.2% |
| Alector Inc(ALEC) | COM | 014442107 | $1.8M | 80,000 | 2.0% |
| Cabaletta BIO Inc(CABA) | COM | 12674W109 | $1.2M | 100,000 | 1.3% |
| Biontech SE(BNTX) | SPONSORED ADS | 09075V102 | $546.0K | 2,000 | 0.6% |
| Ishares TR(IWM)Call | RUSSELL 2000 ETF | 464287655 | $21.9K | 100,000 | 0.0% |
| Iovance Biotherapeutics Inc(IOVA) | COM | 462260100 | $17.3K | 700,000 | 0.0% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $12.1K | 790,000 | 0.0% |
| Iveric BIO Inc(OPHTEUR) | COM | 46583P102 | $11.8K | 725,000 | 0.0% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $11.0K | 575,000 | 0.0% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $10.6K | 60,000 | 0.0% |
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $10.5K | 350,000 | 0.0% |
| Allakos Inc(ALLKGUSD) | COM | 01671P100 | $9.0K | 85,000 | 0.0% |
| GH Research PLC(GHRS) | ORDINARY SHARES | G3855L106 | $8.8K | 400,000 | 0.0% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $8.0K | 425,000 | 0.0% |
| Rapt Therapeutics Inc(RAPTEUR) | COM | 75382E109 | $7.8K | 250,000 | 0.0% |
| Leap Therapeutics Inc | COM | 52187K101 | $6.6K | 1,650,000 | 0.0% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $6.6K | 200,000 | 0.0% |
| Beyondspring Inc(BYSI)Call | SHS | G10830100 | $6.3K | 400,000 | 0.0% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $5.8K | 350,000 | 0.0% |
| Vistagen Therapeutics Inc(VTGNUSD) | COM NEW | 92840H202 | $5.5K | 2,000,000 | 0.0% |
| Relmada Therapeutics Inc(RLMD) | COM | 75955J402 | $5.2K | 200,000 | 0.0% |
| Apellis Pharmaceuticals Inc(APLS)Call | COM | 03753U106 | $4.9K | 150,000 | 0.0% |
| Helix Acquisition Corp | COM CL A | G4444C102 | $4.9K | 500,000 | 0.0% |
| CTI Biopharma Corp(CTIC1USD) | COM | 12648L601 | $4.7K | 1,600,000 | 0.0% |
| Praxis Precision Medicines I | COM | 74006W108 | $4.6K | 250,000 | 0.0% |
| Sierra Oncology Inc | COM NEW | 82640U404 | $4.4K | 200,000 | 0.0% |
| Zentalis Pharmaceuticals Inc(ZNTL) | COM | 98943L107 | $4.3K | 65,000 | 0.0% |
| Satsuma Pharmaceuticals Inc | COM | 80405P107 | $4.2K | 904,225 | 0.0% |
| Verona Pharma PLC(VRNA) | SPONSORED ADS | 925050106 | $4.1K | 750,000 | 0.0% |
| Catalyst Biosciences Inc | COM NEW | 14888D208 | $4.1K | 1,000,000 | 0.0% |
| Tcr2 Therapeutics Inc | COM | 87808K106 | $4.1K | 477,323 | 0.0% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $4.1K | 160,000 | 0.0% |
| Xenon Pharmaceuticals Inc(XENE)Put | COM | 98420N105 | $3.8K | 250,000 | 0.0% |
| Tarsus Pharmaceuticals Inc(TARS) | COM | 87650L103 | $3.7K | 170,000 | 0.0% |
| 9 Meters Biopharma Inc | COM | 654405109 | $3.6K | 2,750,000 | 0.0% |
| Fate Therapeutics Inc(FATE) | COM | 31189P102 | $3.0K | 50,000 | 0.0% |
| Harmony Biosciences Hldgs in(HRMY) | COM | 413197104 | $2.9K | 75,000 | 0.0% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $2.5K | 265,000 | 0.0% |
| Bellus Health Inc New(BLU) | COM NEW | 07987C204 | $2.5K | 400,000 | 0.0% |
| Immunic Inc(IMUX) | COM | 4525EP101 | $2.3K | 265,000 | 0.0% |